{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-22-023674","form_type":"8-K","ticker":"PRLD","cik":"0001678660","company_name":"Prelude Therapeutics Inc","filed_at":"2022-06-21T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.758450+00:00","generated_at":"2026-06-25T00:27:14.038638+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Prelude Therapeutics stockholders elect three Class II directors and ratify auditor at 2022 annual meeting","bullets":["Martin Babler elected with 27,034,110 votes for; 54,875 withheld; 1,215,046 broker non-votes.","Julian Baker elected with 25,635,979 votes for; 1,453,006 withheld; 1,215,046 broker non-votes.","Victor Sandor elected with 26,057,360 votes for; 1,031,625 withheld; 1,215,046 broker non-votes.","Ernst & Young ratified as independent auditor for FY2022: 28,293,151 for, 5,385 against, 5,495 abstain."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-22-023674","json":"https://secwatch.observer/filing/0001564590-22-023674.json","markdown":"https://secwatch.observer/filing/0001564590-22-023674.md","text":"https://secwatch.observer/filing/0001564590-22-023674.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1678660/000156459022023674/0001564590-22-023674-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1678660/000156459022023674/prld-8k_20220617.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T00:27:14.038638+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}